phosphorylcholine has been researched along with lovastatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hennes, U; Himber, J; Kempen, HJ; Missano, B; Rudling, M | 1 |
| Beardsley, NJ; Delikatny, EJ; Jeitner, TM; Milkevitch, M | 1 |
2 other study(ies) available for phosphorylcholine and lovastatin
| Article | Year |
|---|---|
Effects of stigmastanyl-phosphocholine (Ro 16-6532) and lovastatin on lipid and lipoprotein levels and lipoprotein metabolism in the hamster on different diets.
Topics: Animals; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein B-100; Apolipoproteins B; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coconut Oil; Cricetinae; Diet; Dietary Fats; Lactoferrin; Lipids; Lipoproteins; Liver; Lovastatin; Male; Mesocricetus; Phosphorylcholine; Plant Oils; Receptors, LDL; Sitosterols | 1995 |
Lovastatin enhances phenylbutyrate-induced MR-visible glycerophosphocholine but not apoptosis in DU145 prostate cells.
Topics: Animals; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Enzyme Activation; Glycerophosphates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inclusion Bodies; Lipids; Lovastatin; Male; Nuclear Magnetic Resonance, Biomolecular; Phenylbutyrates; Phosphorylcholine; Prostatic Neoplasms; Radiography | 2007 |